Medical and R&D

Cardiac PET

Rb-82 “ARMI” Trial – Completed

Rubidium-82 – An Alternative Radiopharmaceutical for Myocardial Imaging (Rb-ARMI)

In 2014 Canadian Rubidium-82 PET imaging sites transitioned from the Rb-ARMI clinical trial to the REST-PET (Rubidium Elution System Testing) device trial.

There were five clinical sites in Canada registered under the REST-PET trial: the University of Ottawa Heart Institute (Ottawa, ON) is the study sponsor and coordinating centre / St. Joseph’s Healthcare (Hamilton, ON) / KMH Cardiology (Toronto, ON) / University of Alberta Hospital (Edmonton, AB) and Institut Universitaire de Cardiologie et Pneumologie de Québec (Québec, QC).

For more information on the ARMI Trial, please visit:


We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.